SCHEMBL17899117

SCHEMBL17899117

Cc1sc(NC(=O)C2C3CCC(C3)C2C(=O)O)nc1-c1ccc(C(C)C)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.56
KDM4E B2RXH2 1/20 0.56
GAA P10253 1/20 0.56
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
ALDH1A1 P00352 8/20 0.53
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
HTT P42858 2/20 0.48
XIAP P98170 1/20 0.47
LMNA P02545 4/20 0.45
NPSR1 Q6W5P4 2/20 0.45
RECQL P46063 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALOX5 P09917 1/20 0.44
PTPN1 P18031 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1915602 0.81 ALDH1A1 (0.60) MAPTKDM4EGAANPC1RAB9A
SCHEMBL16426670 0.81 MAPT (0.51) MAPTKDM4EGAANPC1RAB9A
SCHEMBL6861634 0.79 ALDH1A1 (0.77) MAPTKDM4EGAANPC1RAB9A
SCHEMBL25259478 0.70 ALDH1A1 (0.73) MAPTKDM4ENPC1RAB9AALDH1A1
SCHEMBL1914959 0.70 ALDH1A1 (0.60) MAPTKDM4EGAANPC1RAB9A
SCHEMBL1915536 0.70 ALDH1A1 (0.60) MAPTKDM4EGAAALDH1A1KMT2A
SCHEMBL31114407 0.70 ALDH1A1 (0.73) MAPTKDM4ENPC1RAB9AALDH1A1
SCHEMBL1915756 0.69 ALDH1A1 (0.62) MAPTKDM4EGAANPC1RAB9A
SCHEMBL1914731 0.69 ALDH1A1 (0.62) MAPTKDM4EGAAALDH1A1CYP1A2
SCHEMBL1915954 0.68 MAPT (0.66) MAPTKDM4EGAARAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266527-B2 T-box riboswitch-binding anti-bacterial compounds THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF ALBANY (US) 2019-04-23 US disclosed
US-20160194317-A1 T-BOX RIBOSWITCH-BINDING ANTI-BACTERIAL COMPOUNDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2016-07-07 US disclosed
US-20160194317-A1 T-BOX RIBOSWITCH-BINDING ANTI-BACTERIAL COMPOUNDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2016-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266527-B2 T-box riboswitch-binding anti-bacterial compounds TARBP1, AARS1, NSUN3 MAPT 4117/4885KDM4E 2123/4885GAA 1464/4885
US-20160194317-A1 T-BOX RIBOSWITCH-BINDING ANTI-BACTERIAL COMPOUNDS TARBP1, AARS1, NSUN3 MAPT 4117/4885KDM4E 2123/4885GAA 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.